Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases.
about
Emerging pharmaceutical therapies for COPD.Hyperresponsiveness: Relating the Intact Airway to the Whole Lung.(-)-Epigallocatechin-3-gallate Reduces Cigarette Smoke-Induced Airway Neutrophilic Inflammation and Mucin Hypersecretion in Rats.Beneficial effects of Red Light-Emitting Diode treatment in experimental model of acute lung injury induced by sepsis.IL-13 in LPS-Induced Inflammation Causes Bcl-2 Expression to Sustain Hyperplastic Mucous cells.Clusterin Induces MUC5AC Expression via Activation of NF-κB in Human Airway Epithelial Cells.Physicochemical properties of mucus and their impact on transmucosal drug delivery.
P2860
Q38645203-1ABAE072-AA35-4A4F-A262-4586C03EA705Q39374000-FA62ED28-AB47-481B-B131-8DF8C09CB1B9Q41439025-D2C859D4-60FA-4703-A549-7BE6B46C9B5AQ42281514-DBB1AB63-F366-47C2-BE0C-59C259F4E65CQ47660154-5D22AE04-FB0B-4250-849B-BE33D1B7B43BQ47662038-92D1395F-F537-4DE9-A016-82D3B31B5D41Q47791593-520C14D0-EBD5-468D-BFE3-2C6E59D887E8
P2860
Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel Therapies to Inhibit Muc ...... irway Hypersecretory Diseases.
@en
type
label
Novel Therapies to Inhibit Muc ...... irway Hypersecretory Diseases.
@en
prefLabel
Novel Therapies to Inhibit Muc ...... irway Hypersecretory Diseases.
@en
P356
P1433
P1476
Novel Therapies to Inhibit Muc ...... irway Hypersecretory Diseases.
@en
P2093
Duncan F Rogers
Emily V S Ha
P304
P356
10.1159/000442794
P577
2015-12-17T00:00:00Z